Metropolis Healthcare Limited — Updates, 07-08-2025: Press Release

Metropolis Healthcare delivered strong Q1FY26 results, with revenue up 23% YoY to INR 386 Crore and PAT increasing 19%. This growth was fueled by 11% patient volume and 12% test volume expansion, alongside improved Revenue per Patient and Test. Specialty Diagnostics saw a robust 32% growth, particularly in Oncology & Genomics. The TruHealth wellness portfolio grew 24%, and geographic reach expanded, with North India's revenue contribution rising to 17%. Acquisitions are successfully integrated, positioning METROPOLIS for sustained profitable growth in a stabilizing diagnostics market.